SHORTER Trial
Cross-source consensus on SHORTER Trial from 1 sources and 5 claims.
1 sources · 5 claims
Comparisons
Other
Other
Highlighted claims
- Participants are randomised equally to a fixed 5-day antibiotic course or standard-of-care antibiotic duration. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- SHORTER is a pragmatic, multicentre, open-label, parallel-arm randomised controlled trial in critically ill adults with suspected or confirmed sepsis. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- The trial will recruit 2244 adults from 50 UK NHS hospitals with critical care units. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- Trial follow-up runs for 90 days from trial day 1. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis
- The trial is open-label because blinding clinical teams to antibiotic duration was considered infeasible. — SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis